skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 468  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
Material Type:
Article
Add to My Research

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management

Vascular health and risk management, 2023-01, Vol.19, p.211-221 [Peer Reviewed Journal]

2023 Litt et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Litt et al. 2023 Litt et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S365001 ;PMID: 37050929

Full text available

2
Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind?
Material Type:
Article
Add to My Research

Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind?

Vascular health and risk management, 2013-01, Vol.9 (default), p.149-154 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Redfors et al, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s40163 ;PMID: 23626469

Full text available

3
Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases
Material Type:
Article
Add to My Research

Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases

Drug design, development and therapy, 2023-01, Vol.17, p.1863-1877 [Peer Reviewed Journal]

2023 Zhang et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Zhang et al. 2023 Zhang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S413136 ;PMID: 37377648

Full text available

4
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
Material Type:
Article
Add to My Research

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies

Vascular health and risk management, 2010-01, Vol.6 (default), p.883-903 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Voulgari et al, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s11681 ;PMID: 21057575

Full text available

5
DNA methylome and transcriptome profiling reveal key electrophysiology and immune dysregulation in hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

DNA methylome and transcriptome profiling reveal key electrophysiology and immune dysregulation in hypertrophic cardiomyopathy

Epigenetics, 2023-12, Vol.18 (1), p.2195307-2195307 [Peer Reviewed Journal]

2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s) ;ISSN: 1559-2294 ;EISSN: 1559-2308 ;DOI: 10.1080/15592294.2023.2195307 ;PMID: 37005704

Full text available

6
Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis

Future science OA, 2023-12, Vol.9 (10), p.FSO898-FSO898 [Peer Reviewed Journal]

2023 The Authors ;2023 The Authors 2023 ;ISSN: 2056-5623 ;EISSN: 2056-5623 ;DOI: 10.2144/fsoa-2023-0059

Full text available

7
Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
Material Type:
Article
Add to My Research

Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study

Annals of medicine (Helsinki), 2023-12, Vol.55 (1), p.2235564-2235564 [Peer Reviewed Journal]

2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2023.2235564 ;PMID: 37467172

Full text available

8
Perinatal versus adult loss of ULK1 and ULK2 distinctly influences cardiac autophagy and function
Material Type:
Article
Add to My Research

Perinatal versus adult loss of ULK1 and ULK2 distinctly influences cardiac autophagy and function

Autophagy, 2022-09, Vol.18 (9), p.2161-2177 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 1554-8627 ;EISSN: 1554-8635 ;DOI: 10.1080/15548627.2021.2022289 ;PMID: 35104184

Full text available

9
Serial evaluation of cardiac biomarker NT-proBNP with speckle tracking echocardiography in a 6-year-old Golden Retriever dog with subaortic stenosis and dilated cardiomyopathy
Material Type:
Article
Add to My Research

Serial evaluation of cardiac biomarker NT-proBNP with speckle tracking echocardiography in a 6-year-old Golden Retriever dog with subaortic stenosis and dilated cardiomyopathy

The Veterinary quarterly, 2020-01, Vol.40 (1), p.77-82 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2020 The Author(s) ;ISSN: 0165-2176 ;EISSN: 1875-5941 ;DOI: 10.1080/01652176.2020.1727992 ;PMID: 32036775

Full text available

10
Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats
Material Type:
Article
Add to My Research

Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats

Drug design, development and therapy, 2016-01, Vol.10, p.2095-2107 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Al-Rasheed et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s109287 ;PMID: 27418808

Full text available

11
U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
Material Type:
Article
Add to My Research

U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients

Upsala journal of medical sciences, 2020-02, Vol.125 (1), p.44-51 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 The Author(s) ;ISSN: 0300-9734 ;EISSN: 2000-1967 ;DOI: 10.1080/03009734.2020.1719245 ;PMID: 32013714

Full text available

12
QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
Material Type:
Article
Add to My Research

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy

Pharmaceutical biology, 2022-12, Vol.60 (1), p.722-728 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2022.2056206 ;PMID: 35361037

Full text available

13
Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats
Material Type:
Article
Add to My Research

Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats

Pharmaceutical biology, 2021-01, Vol.59 (1), p.119-126 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2021.1877736 ;PMID: 33539718

Full text available

14
Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
Material Type:
Article
Add to My Research

Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.1169-1184 [Peer Reviewed Journal]

2021 Huang et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Huang et al. 2021 Huang et al. ;ISSN: 1178-7066 ;EISSN: 1178-7066 ;DOI: 10.2147/PGPM.S323379 ;PMID: 34557019

Full text available

15
Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review
Material Type:
Article
Add to My Research

Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review

Annals of medicine (Helsinki), 2016-10, Vol.48 (7), p.496-508 [Peer Reviewed Journal]

2016 Informa UK Limited, trading as Taylor & Francis Group 2016 ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2016.1187764 ;PMID: 27460395

Digital Resources/Online E-Resources

16
Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
Material Type:
Article
Add to My Research

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions

Drug design, development and therapy, 2023-01, Vol.17, p.1097-1106 [Peer Reviewed Journal]

2023 Dong et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Dong et al. 2023 Dong et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S368590 ;PMID: 37064432

Full text available

17
Fruit vinegars attenuate cardiac injury via anti-inflammatory and anti-adiposity actions in high-fat diet-induced obese rats
Material Type:
Article
Add to My Research

Fruit vinegars attenuate cardiac injury via anti-inflammatory and anti-adiposity actions in high-fat diet-induced obese rats

Pharmaceutical biology, 2017-01, Vol.55 (1), p.43-52 [Peer Reviewed Journal]

2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2016 ;2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/Licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2016 The Author(s). ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2016.1226369 ;PMID: 27595296

Full text available

18
Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report
Material Type:
Article
Add to My Research

Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report

Infection and drug resistance, 2024-01, Vol.17, p.1303-1307 [Peer Reviewed Journal]

2024 Wu et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Wu et al. 2024 Wu et al. ;ISSN: 1178-6973 ;EISSN: 1178-6973 ;DOI: 10.2147/IDR.S449491 ;PMID: 38576823

Full text available

19
Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 10
Material Type:
Article
Add to My Research

Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 10

Channels (Austin, Tex.), 2024-12, Vol.18 (1), p.2355121-2355121 [Peer Reviewed Journal]

2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1933-6950 ;EISSN: 1933-6969 ;DOI: 10.1080/19336950.2024.2355121 ;PMID: 38762910

Full text available

20
Diagnosis and Screening of Patients with Fabry Disease
Material Type:
Article
Add to My Research

Diagnosis and Screening of Patients with Fabry Disease

Therapeutics and clinical risk management, 2020-01, Vol.16, p.551-558 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Vardarli et al. 2020 Vardarli et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S247814 ;PMID: 32606714

Full text available

Results 1 - 20 of 468  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1998  (7)
  2. 1998 To 2003  (12)
  3. 2004 To 2010  (34)
  4. 2011 To 2016  (126)
  5. After 2016  (290)
  6. More options open sub menu

Resource Type 

  1. Articles  (444)
  2. Reports  (23)
  3. Conference Proceedings  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait